Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-07 4:15 pm Purchase | 2022-02-24 | 13G | STANDARD BIOTOOLS INC. LAB | North Sound Trading LP | 4,375,000 5.700% | 4,375,000 (New Position) | Filing History |
| 2022-02-14 3:46 pm Purchase | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management, L.P. | 7,585,905 9.900% | 49,555 (+0.66%) | Filing History |
| 2022-02-11 4:39 pm Sale | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | Russell Investments Group Ltd. | 0 0.000% | -2,250,881 (Position Closed) | Filing History |
| 2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | ORBIMED ADVISORS LLC | 3,416,871 4.460% | -82,375 (-2.35%) | Filing History |
| 2022-02-10 12:24 pm Sale | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | PRIMECAP MANAGEMENT CO/CA/ | 5,093,403 6.660% | -340,440 (-6.27%) | Filing History |
| 2022-02-10 08:11 am Purchase | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | The Vanguard Group | 3,867,671 5.060% | 391,361 (+11.26%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock Inc. BLK | 6,251,230 8.200% | 673,271 (+12.07%) | Filing History |
| 2021-11-18 5:28 pm Sale | 2021-11-18 | 13D | STANDARD BIOTOOLS INC. LAB | Neuberger Berman Group LLC | 4,336,103 5.670% | -308,451 (-6.64%) | Filing History |
| 2021-05-10 5:20 pm Purchase | 2021-04-30 | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 8,380,265 11.200% | 8,380,265 (New Position) | Filing History |